NorthRock Partners’s OptimizeRx OPRX Stock Holding History

NorthRock Partners’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,000	Closed	-$209K	–	247
2020 Q3	$209K	Sell	10,000 -10,031	-50%	-$172K	0.02%	206
2020 Q2	$261K	Sell	20,031 -12,469	-38%	-$136K	0.03%	171
2020 Q1	$294K	Buy	+32,500	New	+$308K	0.04%	143
2019 Q2	–	Sell	-10,000	Closed	-$127K	–	90
2019 Q1	$127K	Sell	10,000 -2,900	-22%	-$37.7K	0.03%	87
2018 Q4	$142K	Buy	+12,900	New	+$191K	0.04%	95

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NorthRock Partners's OPRX Position: Q4 2020 in Review

NorthRock Partners sold out of OptimizeRx (OPRX) in Q4 2020, closing a stake of 10,000 shares — an estimated $209K sold.

NorthRock Partners first reported a position in OPRX in Q4 2018 and held it in 5 quarters. The position peaked at $294K in Q1 2020. 86 funds tracked by Wall St. Rank hold OPRX as of Q4 2020.

NorthRock Partners reported no remaining OptimizeRx position as of Q4 2020 after selling out during the quarter.
NorthRock Partners sold 10,000 OptimizeRx shares in Q4 2020, an estimated $209K.
NorthRock Partners first reported a position in OptimizeRx in Q4 2018 and held it in 5 quarters.
NorthRock Partners's OptimizeRx position peaked at $294K in Q1 2020.
86 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2020.

Based on NorthRock Partners's 13F filing for Q4 2020, filed 8 Feb 2021.